Tag #Long Covid

Showing 37 to 48 of 49 results

kathimerini.gr

🌐 75% Global Worthiness

Jan 10, 01:05

Post-COVID-19 IBS: A Growing Gastrointestinal Concern

Sarah Carter developed post-infectious irritable bowel syndrome (IBS) six months after recovering from COVID-19 in October 2023, experiencing persistent diarrhea, bloating, and abdominal pain; doctors link this to a rise in post-COVID-19 gastrointestinal issues, with studies showing 16-40% of patien...

Post-COVID-19 IBS: A Growing Gastrointestinal Concern

Sarah Carter developed post-infectious irritable bowel syndrome (IBS) six months after recovering from COVID-19 in October 2023, experiencing persistent diarrhea, bloating, and abdominal pain; doctors link this to a rise in post-COVID-19 gastrointestinal issues, with studies showing 16-40% of patien...

Progress

16% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does COVID-19 infection potentially lead to the development of post-infectious irritable bowel syndrome (IBS), and what are the underlying mechanisms?

Carter's case highlights a growing trend among gastroenterologists: a rise in IBS and other gastrointestinal disorders following COVID-19 infections. While precise percentages remain unclear, studies suggest that 16% to 40% of COVID-19 patients experience persistent gastrointestinal symptoms. This increase is attributed to COVID-19's ability to affect cells in the gastrointestinal system, potentially triggering inflammation and disrupting the gut microbiome.

tr.euronews.com

🌐 85% Global Worthiness

Jan 3, 16:09

COVID-19 at Five Years: Evolving Virus, Uncertain Origin, and Lingering Health Impacts

Five years after the initial COVID-19 outbreak in Wuhan, China, the pandemic's global death toll is estimated to be over 20 million, with the virus continuing to evolve and long COVID impacting millions. The origin remains uncertain, hampered by lack of transparency from China.

COVID-19 at Five Years: Evolving Virus, Uncertain Origin, and Lingering Health Impacts

Five years after the initial COVID-19 outbreak in Wuhan, China, the pandemic's global death toll is estimated to be over 20 million, with the virus continuing to evolve and long COVID impacting millions. The origin remains uncertain, hampered by lack of transparency from China.

Progress

12% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the leading theories regarding the origin of SARS-CoV-2, and what obstacles hinder definitive conclusions?

The pandemic exposed deep inequalities in global health systems, highlighting disparities in access to vaccines and healthcare. The exact origin of SARS-CoV-2 remains uncertain, with the most likely theory pointing to a zoonotic origin, potentially through an intermediary animal host before transmission to humans in Wuhan. Political tensions and a lack of complete transparency from China have hindered investigations.

nos.nl

🌐 85% Global Worthiness

Dec 27, 13:09

Funding Cut Jeopardizes Children's Long COVID Care in Netherlands

The Dutch government's rejection of €21 million for researching children's long COVID treatments threatens the 2025 opening of specialized clinics and delays effective care for an estimated 40,000 affected children, with thousands already severely impacted.

Funding Cut Jeopardizes Children's Long COVID Care in Netherlands

The Dutch government's rejection of €21 million for researching children's long COVID treatments threatens the 2025 opening of specialized clinics and delays effective care for an estimated 40,000 affected children, with thousands already severely impacted.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate consequences of the Dutch government's rejection of funding for children's long COVID research?

The Dutch government's rejection of €21 million for researching children's long COVID treatments jeopardizes the planned opening of specialized clinics in 2025. This lack of funding casts doubt on the ability to scientifically validate promising treatments, potentially leaving thousands of children without access to necessary care. The current situation contrasts sharply with the hope for timely treatment.

elpais.com

🌐 85% Global Worthiness

Dec 13, 10:10

"Long COVID in Spain: Unclear Prevalence, Urgent Need for Improved Care"

"In Spain, five years after the initial coronavirus outbreak, the exact number of long COVID sufferers remains unknown, due to the lack of a specific test. While estimates reach millions, the ongoing impact and the prevalence of chronic symptoms are not precisely known. The situation highlights the ...

"Long COVID in Spain: Unclear Prevalence, Urgent Need for Improved Care"

"In Spain, five years after the initial coronavirus outbreak, the exact number of long COVID sufferers remains unknown, due to the lack of a specific test. While estimates reach millions, the ongoing impact and the prevalence of chronic symptoms are not precisely known. The situation highlights the ...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

"What is the current understanding of long COVID's prevalence and impact on the Spanish population, considering diagnostic challenges and evolving knowledge?"

"Five years after the first detection of coronavirus in China, the exact number of people suffering from long COVID remains unknown. This illness is undetectable through standard biological tests, leading to frequent misunderstandings from society and some doctors who doubt its existence. Patients often face accusations of malingering, hindering their ability to work and access appropriate care.", "A significant challenge is the lack of a specific diagnostic test, making it difficult to accurately determine prevalence. Estimates suggest millions affected in Spain alone, but these figures are outdated due to the evolving nature of long COVID and the lack of ongoing monitoring. The variability of symptoms and the long-term impact on individuals further complicate the situation.", "Looking ahead, there's a critical need for improved medical training and resources. The creation of multidisciplinary units is essential, to coordinate care and improve diagnostic accuracy. Further research into effective treatments is vital, given the absence of a specific cure, and to evaluate numerous unproven treatments currently used."

nos.nl

🌐 75% Global Worthiness

Dec 5, 10:09

Dutch Parliament to Reject €21 Million for Long-COVID Research

The Dutch parliament is set to reject a €21 million amendment for long-COVID research, potentially delaying effective symptom management for almost half a million patients, as the government prioritizes existing research results.

Dutch Parliament to Reject €21 Million for Long-COVID Research

The Dutch parliament is set to reject a €21 million amendment for long-COVID research, potentially delaying effective symptom management for almost half a million patients, as the government prioritizes existing research results.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

Will the Dutch parliament approve the €21 million amendment for additional long-COVID research, and what are the immediate consequences for patients if it fails?

Dutch patient advocacy groups warn that a lack of funding for long-COVID research may hinder large-scale treatment. A parliamentary vote on a €21 million research budget amendment is expected to fail, delaying effective symptom management for almost half a million patients. While tens of millions are spent on research into long-COVID causes, few studies focus on repurposing existing drugs to alleviate symptoms.

nos.nl

🌐 75% Global Worthiness

Dec 5, 10:08

Dutch Parliament Rejects Funding for Long COVID Research

A proposed €21 million research budget for long COVID symptom treatment in the Netherlands is facing defeat in parliament, delaying large-scale treatment for nearly half a million patients due to budgetary constraints and competing priorities within the government.

Dutch Parliament Rejects Funding for Long COVID Research

A proposed €21 million research budget for long COVID symptom treatment in the Netherlands is facing defeat in parliament, delaying large-scale treatment for nearly half a million patients due to budgetary constraints and competing priorities within the government.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of insufficient funding for long COVID symptom research in the Netherlands?

Dutch patient advocacy groups warn that a lack of funding for long COVID research may hinder treatment for almost half a million patients. A parliamentary amendment requesting €21 million for additional research lacks majority support, jeopardizing large-scale treatment efforts. While tens of millions are spent on researching long COVID causes, few studies focus on repurposing existing medications to alleviate symptoms, which is currently the most achievable goal.

es.euronews.com

🌐 85% Global Worthiness

Jan 9, 07:05

COVID-19: Five Years Later—Deaths, Variants, and Lingering Impacts

Five years after the COVID-19 pandemic began, over 20 million deaths are estimated, with the Omicron variant currently dominant; however, scientists are developing new vaccines and researching the lingering effects of long COVID.

COVID-19: Five Years Later—Deaths, Variants, and Lingering Impacts

Five years after the COVID-19 pandemic began, over 20 million deaths are estimated, with the Omicron variant currently dominant; however, scientists are developing new vaccines and researching the lingering effects of long COVID.

Progress

28% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the estimated death toll from COVID-19, and what ongoing challenges does the virus pose to global health?

Five years after the start of the COVID-19 pandemic, over 20 million deaths are estimated, with the actual number potentially three times higher than officially reported. Scientists developed vaccines in record time, saving millions of lives, though the virus continues to evolve, requiring updated vaccines. The Omicron variant, and its subvariants, currently dominates, causing less severe illness than previous strains.

abcnews.go.com

🌐 90% Global Worthiness

Jan 2, 22:08

COVID-19 Pandemic: 20 Million Deaths, Ongoing Evolution, and Long-Term Health Impacts

The COVID-19 pandemic, originating in Wuhan, China in late 2019, has caused an estimated 20 million deaths globally, exposed global health inequities, and resulted in the debilitating condition known as "long COVID," despite the development of effective vaccines.

COVID-19 Pandemic: 20 Million Deaths, Ongoing Evolution, and Long-Term Health Impacts

The COVID-19 pandemic, originating in Wuhan, China in late 2019, has caused an estimated 20 million deaths globally, exposed global health inequities, and resulted in the debilitating condition known as "long COVID," despite the development of effective vaccines.

Progress

16% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the global impact of COVID-19, including its death toll and ongoing challenges?

The COVID-19 pandemic, originating in Wuhan, China in late 2019, has resulted in an estimated 20 million deaths globally. Despite the development of effective vaccines and the virus's reduced lethality, it continues to evolve, necessitating ongoing monitoring and updated vaccinations.

bbc.com

🌐 85% Global Worthiness

Dec 26, 13:07

Long COVID: Blood Biomarkers, Paxlovid Trials, and Repeated Infection Risks

Research worldwide reveals potential biomarkers for long COVID, including unusual T-cell activity and elevated interferon-gamma, with studies exploring the antiviral drug Paxlovid's impact and the link between repeated COVID infections and long COVID risk.

Long COVID: Blood Biomarkers, Paxlovid Trials, and Repeated Infection Risks

Research worldwide reveals potential biomarkers for long COVID, including unusual T-cell activity and elevated interferon-gamma, with studies exploring the antiviral drug Paxlovid's impact and the link between repeated COVID infections and long COVID risk.

Progress

24% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What biological evidence supports the existence of long COVID, and what are the immediate implications for diagnosis and treatment?

Akiko Iwasaki's research at Yale has identified blood biomarkers that can distinguish between long COVID patients and others with 96% accuracy. This suggests a biological basis for long COVID, although further research is needed to develop simple diagnostic tests. Current research is exploring the antiviral drug Paxlovid's potential to mitigate long COVID symptoms.

nrc.nl

🌐 75% Global Worthiness

Dec 9, 04:05

Long COVID Crisis: Dutch Employers Face Dilemma Over Employee Dismissals

Approximately 450,000 Dutch citizens suffer from long COVID, with 90,000 facing severe symptoms. The UWV anticipates most affected employees will become unfit for work after two years of sick leave, forcing employers to choose between continued financial burden or dismissal.

Long COVID Crisis: Dutch Employers Face Dilemma Over Employee Dismissals

Approximately 450,000 Dutch citizens suffer from long COVID, with 90,000 facing severe symptoms. The UWV anticipates most affected employees will become unfit for work after two years of sick leave, forcing employers to choose between continued financial burden or dismissal.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of the rising number of long COVID cases on the Dutch labor market and social security system?

In the Netherlands, an estimated 450,000 people suffer from long COVID, with 90,000 experiencing severe symptoms. The UWV, a Dutch benefits agency, anticipates most working long COVID patients will eventually be declared unfit for work, leading to increased WIA disability benefit applications. This is primarily due to the rising number of long COVID cases.

nos.nl

🌐 75% Global Worthiness

Dec 5, 10:09

Dutch Parliament Fails to Secure Funding for Long COVID Treatment Research

A Dutch parliamentary amendment seeking €21 million for long COVID treatment research is likely to fail, delaying widespread treatment for nearly half a million patients, despite existing research into the disease's causes.

Dutch Parliament Fails to Secure Funding for Long COVID Treatment Research

A Dutch parliamentary amendment seeking €21 million for long COVID treatment research is likely to fail, delaying widespread treatment for nearly half a million patients, despite existing research into the disease's causes.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of insufficient funding for long COVID research on patients?

Dutch patient advocacy groups fear a lack of funding for additional research into long COVID treatment. A parliamentary amendment requesting €21 million for this research lacks majority support, hindering large-scale treatment for nearly half a million patients. This is despite tens of millions already spent on researching long COVID causes.

milano.repubblica.it

🌐 85% Global Worthiness

Dec 1, 16:54

Long Covid Sufferer Faces Systemic Healthcare Barriers

Colombian Erika, a long Covid sufferer with 85% disability, faces challenges accessing adequate healthcare and financial support due to bureaucratic hurdles, delayed employer reporting, and inadequate union representation, highlighting systemic issues within healthcare and worker protection.

Long Covid Sufferer Faces Systemic Healthcare Barriers

Colombian Erika, a long Covid sufferer with 85% disability, faces challenges accessing adequate healthcare and financial support due to bureaucratic hurdles, delayed employer reporting, and inadequate union representation, highlighting systemic issues within healthcare and worker protection.

Progress

56% Bias Score

ShareSaveArticle

12345678

Previous 1 of 8 Next

What immediate actions are needed to ensure adequate healthcare access and financial support for long Covid sufferers like Erika, especially considering bureaucratic and systemic barriers?

Erika, a Colombian woman, suffered severe long Covid after a delayed implementation of smart working and inadequate safety measures at her German multinational employer. This resulted in a four-month Covid infection, job loss, and debilitating neurological, respiratory, and immune system damage. She now faces chronic pain, fatigue, and cognitive impairment.

Showing 37 to 48 of 49 results